These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 20607539)

  • 21. Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection.
    Pincus NB; Reckhow JD; Saleem D; Jammeh ML; Datta SK; Myles IA
    PLoS One; 2015; 10(4):e0124280. PubMed ID: 25909449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bacteriophage reduces biofilm of Staphylococcus aureus ex vivo isolates from chronic rhinosinusitis patients.
    Drilling A; Morales S; Jardeleza C; Vreugde S; Speck P; Wormald PJ
    Am J Rhinol Allergy; 2014; 28(1):3-11. PubMed ID: 24717868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibacterial Effects of Phage Lysin LysGH15 on Planktonic Cells and Biofilms of Diverse Staphylococci.
    Zhang Y; Cheng M; Zhang H; Dai J; Guo Z; Li X; Ji Y; Cai R; Xi H; Wang X; Xue Y; Sun C; Feng X; Lei L; Han W; Gu J
    Appl Environ Microbiol; 2018 Aug; 84(15):. PubMed ID: 29776929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant
    Lehman SM; Mearns G; Rankin D; Cole RA; Smrekar F; Branston SD; Morales S
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30669652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.
    Paul VD; Sundarrajan S; Rajagopalan SS; Hariharan S; Kempashanaiah N; Padmanabhan S; Sriram B; Ramachandran J
    BMC Microbiol; 2011 Aug; 11():195. PubMed ID: 21880144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacteriophage Therapy for the Prevention and Treatment of Fracture-Related Infection Caused by Staphylococcus aureus: a Preclinical Study.
    Onsea J; Post V; Buchholz T; Schwegler H; Zeiter S; Wagemans J; Pirnay JP; Merabishvili M; D'Este M; Rotman SG; Trampuz A; Verhofstad MHJ; Obremskey WT; Lavigne R; Richards RG; Moriarty TF; Metsemakers WJ
    Microbiol Spectr; 2021 Dec; 9(3):e0173621. PubMed ID: 34908439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strategy for mass production of lytic Staphylococcus aureus bacteriophage pSa-3: contribution of multiplicity of infection and response surface methodology.
    Kim SG; Kwon J; Giri SS; Yun S; Kim HJ; Kim SW; Kang JW; Lee SB; Jung WJ; Park SC
    Microb Cell Fact; 2021 Mar; 20(1):56. PubMed ID: 33653327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of a novel Staphylococcus aureus bacteriophage, phiMR25, and its therapeutic potential.
    Hoshiba H; Uchiyama J; Kato S; Ujihara T; Muraoka A; Daibata M; Wakiguchi H; Matsuzaki S
    Arch Virol; 2010 Apr; 155(4):545-52. PubMed ID: 20224894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool.
    Kaźmierczak Z; Górski A; Dąbrowska K
    Viruses; 2014 Jul; 6(7):2551-70. PubMed ID: 24988520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic action of phage phiIPLA-RODI and lytic protein CHAPSH3b: a combination strategy to target Staphylococcus aureus biofilms.
    Duarte AC; Fernández L; De Maesschalck V; Gutiérrez D; Campelo AB; Briers Y; Lavigne R; Rodríguez A; García P
    NPJ Biofilms Microbiomes; 2021 Apr; 7(1):39. PubMed ID: 33888725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand.
    Gutiérrez D; Rodríguez-Rubio L; García P; Billington C; Premarante A; Rodríguez A; Martínez B
    Int J Food Microbiol; 2016 Aug; 230():16-20. PubMed ID: 27111797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Combination utility of phages GH15 and K against Staphylococcus aureus].
    Liu X; Gu J; Han W; Li Y; Han D; Zhang Q; Lu R; Song J; Feng X; Lei L
    Wei Sheng Wu Xue Bao; 2013 May; 53(5):498-506. PubMed ID: 23957155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staphylococcal Phage in Combination with Staphylococcus Epidermidis as a Potential Treatment for Staphylococcus Aureus-Associated Atopic Dermatitis and Suppressor of Phage-Resistant Mutants.
    Shimamori Y; Mitsunaka S; Yamashita H; Suzuki T; Kitao T; Kubori T; Nagai H; Takeda S; Ando H
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33375201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains.
    Kwiatek M; Parasion S; Mizak L; Gryko R; Bartoszcze M; Kocik J
    Arch Virol; 2012 Feb; 157(2):225-34. PubMed ID: 22045271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prophylactic administration of bacteriophages to immunosuppressed mice infected with Staphylococcus aureus.
    Zimecki M; Artym J; Kocieba M; Weber-Dabrowska B; Borysowski J; Górski A
    BMC Microbiol; 2009 Aug; 9():169. PubMed ID: 19686585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of
    Freyberger HR; He Y; Roth AL; Nikolich MP; Filippov AA
    Viruses; 2018 Nov; 10(11):. PubMed ID: 30413044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of phage cocktail AB-SA01 therapy in diabetic mouse wound infections caused by multidrug-resistant Staphylococcus aureus.
    Kifelew LG; Warner MS; Morales S; Vaughan L; Woodman R; Fitridge R; Mitchell JG; Speck P
    BMC Microbiol; 2020 Jul; 20(1):204. PubMed ID: 32646376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluating the potential efficacy and limitations of a phage for joint antibiotic and phage therapy of
    Berryhill BA; Huseby DL; McCall IC; Hughes D; Levin BR
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33649203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective treatment of a broad-host-range lytic phage SapYZU15 in eliminating Staphylococcus aureus from subcutaneous infection.
    Wen H; Zhou W; Wu Y; Li Y; Zhu G; Zhang Z; Gu X; Wang C; Yang Z
    Microbiol Res; 2023 Nov; 276():127484. PubMed ID: 37659336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The lytic activity of recombinant phage lysin LysKΔamidase against staphylococcal strains associated with bovine and human infections in the Jiangsu province of China.
    Zhou Y; Zhang H; Bao H; Wang X; Wang R
    Res Vet Sci; 2017 Apr; 111():113-119. PubMed ID: 28235706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.